• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质性肺病的危险因素:一项为期 9 年的全国基于人群的研究。

Risk factors for interstitial lung disease: a 9-year Nationwide population-based study.

机构信息

Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, 41931, Republic of Korea.

Department of Allergology, Hospital Serive of Kavaje, Kavaje, Albania.

出版信息

BMC Pulm Med. 2018 Jun 4;18(1):96. doi: 10.1186/s12890-018-0660-2.

DOI:10.1186/s12890-018-0660-2
PMID:29866093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5987651/
Abstract

BACKGROUND

Understanding the risk factors that are associated with the development of interstitial lung disease might have an important role in understanding the pathogenetic mechanism of interstitial lung disease as well as prevention. We aimed to determine independent risk factors of interstitial lung disease development.

METHODS

This was a retrospective cohort study with nationwide population-based 9-year longitudinal data. We selected subjects who were aged > 40 years at cohort entry and with a self-reported history of cigarette smoking. Cases were selected based on International Classification of Diseases codes. A cohort of 312,519 subjects were followed until December 2013. We used Cox regression analysis to calculate the hazard ratios (HRs) for interstitial lung disease development.

RESULTS

Interstitial lung disease developed in 1972 of the 312,519 subjects during the 9-year period. Smoking (HR: 1.2; 95% confidence interval [CI]: 1.1-1.4), hepatitis C (HR: 1.6; 95% CI: 1.1-2.3), history of tuberculosis (HR: 1.5; 95% CI: 1.1-1.9), history of pneumonia (HR: 1.6; 95% CI: 1.3-2.0), and chronic obstructive pulmonary disease (HR: 1.8; 95% CI: 1.6-2.1), men (HR: 1.9; 95% CI: 1.7-2.1) were significantly associated with the development of interstitial lung disease. The risk of interstitial lung disease development increases with age, and the risk was 6.9 times higher (95% CI: 5.9-8.0) in those aged over 70 than in their forties.

CONCLUSIONS

Smoking, hepatitis C, history of tuberculosis, history of pneumonia, chronic obstructive pulmonary disease, male sex, and older age were significantly associated with interstitial lung disease development.

摘要

背景

了解与间质性肺疾病发展相关的危险因素,对于理解间质性肺疾病的发病机制以及预防可能具有重要作用。我们旨在确定间质性肺疾病发展的独立危险因素。

方法

这是一项基于全国人口的 9 年纵向研究的回顾性队列研究。我们选择了在队列入组时年龄>40 岁且有吸烟史的患者作为研究对象。病例是根据国际疾病分类代码选择的。共有 312519 名受试者接受了随访,随访至 2013 年 12 月。我们使用 Cox 回归分析计算了间质性肺疾病发展的风险比(HR)。

结果

在 9 年的时间里,312519 名受试者中有 1972 名发生了间质性肺疾病。吸烟(HR:1.2;95%置信区间[CI]:1.1-1.4)、丙型肝炎(HR:1.6;95% CI:1.1-2.3)、结核病史(HR:1.5;95% CI:1.1-1.9)、肺炎史(HR:1.6;95% CI:1.3-2.0)和慢性阻塞性肺疾病(HR:1.8;95% CI:1.6-2.1)、男性(HR:1.9;95% CI:1.7-2.1)与间质性肺疾病的发展显著相关。间质性肺疾病的发病风险随年龄增长而增加,70 岁以上人群的发病风险是 40 岁人群的 6.9 倍(95% CI:5.9-8.0)。

结论

吸烟、丙型肝炎、结核病史、肺炎史、慢性阻塞性肺疾病、男性和年龄较大与间质性肺疾病的发展显著相关。

相似文献

1
Risk factors for interstitial lung disease: a 9-year Nationwide population-based study.间质性肺病的危险因素:一项为期 9 年的全国基于人群的研究。
BMC Pulm Med. 2018 Jun 4;18(1):96. doi: 10.1186/s12890-018-0660-2.
2
Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.吸入糖皮质激素后发生的肺结核和肺炎会增加慢性阻塞性肺疾病(COPD)患者患肺癌的风险。
BMC Cancer. 2016 Oct 10;16(1):778. doi: 10.1186/s12885-016-2838-4.
3
Interstitial lung disease and risk of mortality: 11-year nationwide population-based study.间质性肺病与死亡率风险:一项为期 11 年的全国范围基于人群的研究。
Int J Tuberc Lung Dis. 2018 Jan 1;22(1):100-105. doi: 10.5588/ijtld.17.0167.
4
Trends and risk factors of elderly-onset Crohn's disease: A nationwide cohort study.老年发病克罗恩病的趋势和风险因素:一项全国性队列研究。
World J Gastroenterol. 2020 Jan 28;26(4):404-415. doi: 10.3748/wjg.v26.i4.404.
5
The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.哮喘、慢性阻塞性肺疾病和肺结核并存对肺鳞状细胞癌患者生存的影响
PLoS One. 2015 Jul 21;10(7):e0133367. doi: 10.1371/journal.pone.0133367. eCollection 2015.
6
Smoking is associated with pneumonia development in lung cancer patients.吸烟与肺癌患者肺炎的发生有关。
BMC Pulm Med. 2020 May 1;20(1):117. doi: 10.1186/s12890-020-1160-8.
7
The effects of pulmonary diseases on histologic types of lung cancer in both sexes: a population-based study in Taiwan.肺部疾病对两性肺癌组织学类型的影响:一项基于台湾人群的研究。
BMC Cancer. 2015 Nov 2;15:834. doi: 10.1186/s12885-015-1847-z.
8
Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea.韩国不吸烟者中慢性阻塞性肺疾病的危险因素。
Int J Chron Obstruct Pulmon Dis. 2015 Mar 5;10:497-506. doi: 10.2147/COPD.S77662. eCollection 2015.
9
Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population-based cohort study.既往呼吸系统疾病对肺癌患者生存的影响:一项基于全国人群的队列研究。
Asia Pac J Clin Oncol. 2018 Apr;14(2):e71-e80. doi: 10.1111/ajco.12697. Epub 2017 Aug 1.
10
Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.COPD 患者合并肺部疾病与社区获得性肺炎风险。
Int J Tuberc Lung Dis. 2013 Dec;17(12):1638-44. doi: 10.5588/ijtld.13.0330.

引用本文的文献

1
Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis.衰老相关的白细胞介素-11驱动特发性肺纤维化的分子机制及靶向治疗
Eur J Med Res. 2025 Jul 2;30(1):542. doi: 10.1186/s40001-025-02755-5.
2
Nobiletin's role in idiopathic pulmonary fibrosis via the PI3K/AKT/MDM2/p53 signaling pathway.诺比列汀通过PI3K/AKT/MDM2/p53信号通路在特发性肺纤维化中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 2. doi: 10.1007/s00210-025-04270-0.
3
Mitochondrial dysfunction and alveolar type II epithelial cell senescence: The destroyer and rescuer of idiopathic pulmonary fibrosis.

本文引用的文献

1
Interstitial lung disease and risk of mortality: 11-year nationwide population-based study.间质性肺病与死亡率风险:一项为期 11 年的全国范围基于人群的研究。
Int J Tuberc Lung Dis. 2018 Jan 1;22(1):100-105. doi: 10.5588/ijtld.17.0167.
2
Interstitial Lung Disease and Lung Cancer Development: A 5-Year Nationwide Population-Based Study.间质性肺疾病与肺癌发展:一项为期 5 年的全国性基于人群的研究。
Cancer Res Treat. 2018 Apr;50(2):374-381. doi: 10.4143/crt.2017.119. Epub 2017 May 8.
3
Many Faces of Bronchiolitis and Organizing Pneumonia.细支气管炎和机化性肺炎的多种表现
线粒体功能障碍与肺泡II型上皮细胞衰老:特发性肺纤维化的破坏者与拯救者。
Front Cell Dev Biol. 2025 Mar 31;13:1535601. doi: 10.3389/fcell.2025.1535601. eCollection 2025.
4
High matrix stiffness promotes senescence of type II alveolar epithelial cells by lysosomal degradation of lamin A/C in pulmonary fibrosis.高基质硬度通过肺纤维化中核纤层蛋白A/C的溶酶体降解促进II型肺泡上皮细胞衰老。
Respir Res. 2025 Apr 9;26(1):128. doi: 10.1186/s12931-025-03201-0.
5
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland.2004年至2023年间哮喘、慢性阻塞性肺疾病和间质性肺疾病的发病率和患病率:对英格兰、威尔士、苏格兰东南部和北爱尔兰纵向队列的统一分析
Thorax. 2025 Jun 16;80(7):466-477. doi: 10.1136/thorax-2024-222699.
6
Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT.全身炎症和疾病活动对类风湿关节炎患者间质性肺疾病发病率的影响——德国生物制剂注册库RABBIT中的一项巢式病例对照研究
Arthritis Res Ther. 2024 Dec 5;26(1):209. doi: 10.1186/s13075-024-03449-9.
7
A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system.一项基于美国食品药品监督管理局不良事件报告系统的KRAS G12C突变抑制剂的真实世界药物警戒研究。
Front Pharmacol. 2024 Aug 28;15:1418469. doi: 10.3389/fphar.2024.1418469. eCollection 2024.
8
Quantitative Imaging Methods in Combined Pulmonary Fibrosis and Emphysema.联合肺纤维化和肺气肿的定量成像方法
Chest. 2024 Dec;166(6):1463-1472. doi: 10.1016/j.chest.2024.08.007. Epub 2024 Aug 16.
9
Why making smoking cessation a priority for rare interstitial lung disease smokers?为何要将戒烟作为罕见间质性肺病吸烟者的首要任务?
Tob Prev Cessat. 2024 Jun 28;10. doi: 10.18332/tpc/190591. eCollection 2024.
10
Curculigoside Attenuates Endoplasmic Reticulum Stress-Induced Epithelial Cell and Fibroblast Senescence by Regulating the SIRT1-P300 Signaling Pathway.仙茅苷通过调节SIRT1-P300信号通路减轻内质网应激诱导的上皮细胞和成纤维细胞衰老。
Antioxidants (Basel). 2024 Mar 29;13(4):420. doi: 10.3390/antiox13040420.
Semin Respir Crit Care Med. 2016 Jun;37(3):421-40. doi: 10.1055/s-0036-1582013. Epub 2016 May 27.
4
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.美国 18-64 岁成年人特发性肺纤维化的发病率和患病率。
Eur Respir J. 2016 Jul;48(1):179-86. doi: 10.1183/13993003.01653-2015. Epub 2016 Apr 28.
5
Association Between Interstitial Lung Abnormalities and All-Cause Mortality.间质性肺异常与全因死亡率之间的关联
JAMA. 2016 Feb 16;315(7):672-81. doi: 10.1001/jama.2016.0518.
6
Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.队列简介:韩国国民健康保险服务国家样本队列(NHIS-NSC)
Int J Epidemiol. 2017 Apr 1;46(2):e15. doi: 10.1093/ije/dyv319.
7
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.美国自动索赔中的特发性肺纤维化。发病率、患病率和算法验证。
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1200-7. doi: 10.1164/rccm.201504-0818OC.
8
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.特发性肺纤维化的全球发病率和死亡率:系统评价。
Eur Respir J. 2015 Sep;46(3):795-806. doi: 10.1183/09031936.00185114. Epub 2015 May 14.
9
Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement.基于2011年美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科协会声明的韩国特发性肺纤维化发病率
Int J Tuberc Lung Dis. 2015 Jun;19(6):742-6. doi: 10.5588/ijtld.14.0650.
10
An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features.特发性肺纤维化合并肺气肿的尸检研究:临床、影像学和病理学特征的相关性。
BMC Pulm Med. 2014 Jun 28;14:104. doi: 10.1186/1471-2466-14-104.